Is the domestic price of bosutinib expensive?

Bosutinib (Bosutinib) is an orally active dual Src/Abl tyrosine kinase inhibitor used to treat chronic myeloid leukemia (CML) that is resistant/intolerant to previous treatments. The most common toxicities are mainly gastrointestinal adverse events, including diarrhea, nausea, and vomiting, which are mainly mild to moderate, usually transient, and first occur early in treatment. The original drug of bosutinib is not on the market in China, so it is impossible to know its domestic price. Currently, the original drugs sold overseas include Turkish and European versions, and the price may range from several thousand to tens of thousands of RMB (the price may fluctuate due to the exchange rate).